NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球流感疫苗市場:2020-2027

Global Flu Vaccine Market, Size, Share, Opportunities and Forecast, 2020-2027

出版商 DataM Intelligence 商品編碼 990436
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
全球流感疫苗市場:2020-2027 Global Flu Vaccine Market, Size, Share, Opportunities and Forecast, 2020-2027
出版日期: 2021年04月03日內容資訊: 英文 180 Pages
簡介

流感疫苗市場公司正在加大研發力度,以開發可以治療COVID-19的創新疫苗。預計增加流感疫苗的可獲得性將減輕醫療保健系統的壓力,並最大程度地減少接觸COVID-19的風險。

本報告研究和分析全球流感疫苗市場,並提供有關行業分析,細分市場分析,競爭狀況,主要公司等的系統信息。

目錄

第1章全球流感疫苗市場的調查方法和調查範圍

第2章全球流感疫苗市場:市場定義和市場概述

第3章全球流感疫苗市場:執行摘要

第4章全球流感疫苗市場:市場動態

  • 影響市場的因素
    • 促進因素
    • 抑製器
    • 機會
    • 影響分析

第5章全球流感疫苗市場:行業分析

  • 波特的五種力量分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 價格分析
  • 監管分析
  • 贖回分析
  • 未滿足的需求
  • 專利趨勢

第6章全球流感疫苗市場:COVID-19分析

  • 針對市場的COVID-19分析
  • COVID-19的價格趨勢
  • 供需範圍
  • 大流行期間與市場有關的政府舉措
  • 製造商的戰略計劃
  • 結論

第7章全球流感疫苗市場:按類型

  • 簡介
  • 按類型細分的市場規模分析/同比增長率分析
  • 按類別劃分的市場吸引力指數
    • 全病毒疫苗
    • 分裂病毒疫苗
    • 亞單位疫苗
    • 減毒活病毒疫苗

第8章全球流感疫苗市場:通過分銷渠道

  • 簡介
  • 按分銷渠道細分的市場規模分析和同比增長率分析
  • 按分銷渠道細分的市場吸引力指數
    • 機構
    • 醫院
    • 當地診所
    • 保健中心
    • 工作場所
    • 零售
    • 零售藥房
    • 郵購藥房

第9章全球流感疫苗市場:按用途

  • 簡介
  • 按應用細分市場規模和同比增長率分析
  • 按應用領域劃分的市場吸引力指數
    • 3歲以下的兒童
    • 適用於3歲以上的成人和兒童

第10章全球流感疫苗市場:按地區

  • 簡介
  • 按地區/按年增長率分析的市場規模分析
  • 各地區市場吸引力指數
  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第11章全球流感疫苗市場:競爭形勢

  • 衝突情況
  • 市場定位/份額分析
  • 併購分析

第12章全球流感疫苗市場:公司概況

  • AstraZeneca
  • GlaxoSmithKline PLC
  • Sanofi
  • Abbott Laboratories
  • Seqirus
  • Mitsubishi Tanabe Pharma
  • Serum Institute of India Pvt. Ltd
  • Mylan NV
  • GDK Biotechnology
  • Hualan Biological Engineering Inc.
  • Adimmune Corporation
  • Sinovac Biotech
  • Changchun Institute of Biological Products、スジ

第13章全球流感疫苗市場:重要思想

第14章全球流感疫苗市場:DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Global Flu Vaccine Market is Segmented By Type Segment (Whole virus vaccines, Split vurus vaccines, Subunit vaccines, Live attenuated virus vaccines), By Distribution Channel Segment, Institutional,, Hospitals, Community clinics, Public health agencies, Workplaces, Retails, Retail pharmacy, Mail order pharmacy), By Application Segment (For Children below 3 years, For Adults and Children over 3 years), And By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Flu Vaccine Market is expected to grow at a high CAGR during the forecasting period (2020-2027).

The flu vaccine is an inactivated vaccine, indicating that it includes killed influenza virus, or a recombinant vaccine, implying that it was made without exploiting virus particles. Healthcare providers infuse the vaccine into muscles or skin, encouraging the immune system to produce antibodies to the influenza virus. Medical professionals administer the flu shot vaccine as a single dose of liquid injected through the skin into the muscle. The health care professionals inject the flu vaccine into the deltoid muscle at the side of the arm, using alcohol rubbed over the skin for sterilization.

Source: DataM Intelligence Analysis (2019)

Market Dynamics

Market players in the flu vaccines are increasing their R&D activities to develop innovative vaccines that can treat COVID-19. They are helping persons to refrain from visiting the doctors amidst ongoing pandemic. Increased flu vaccines availability is expected to reduce the stress on healthcare systems and minimize exposure to COVID-19.

Sustained Investments Help to Scale-up Production of Tailor-made Flu Vaccines

The demand for universal flu vaccines increases innovative science and financing to join forces to support exploit on untapped opportunities. Rapid arrival of influenza is expected to overtake the prevailing flu vaccine production technologies; therefore, resulting in increased costs of flu shots which is comparatively ominous for individuals. Thus, there is a need for continuous investments in both technical and financial to innovate in universal flu vaccines. The flu vaccines market's market players are focusing on upgrading the flu vaccine manufacturing processes to rise the production of tailor-made vaccines.

Universal Flu Vaccines: A Cost-efficient Way to Combat Multiple Viral Strains

Single vaccine that safeguards against all flu is another groundbreaking concept gaining market players' traction in the flu vaccines market. Moreover, the manufacturers are increasing their focus in mini-HA (Hemagglutinin) antigens that include parts of the flu virus that are found in numerous other viruses. Universal flu vaccines assist in reducing the burden of yearly updates in flu shots; therefore, saving on costs for researchers and pharma companies.

COVID-19 Impact Analysis

COVID-19 pandemic affected the global supply chain and parallel affects the global economy in many aspects, such as consumption, demand, financial, and supply chain disruption. COVID-19 outburst has directly impacted the manufacturers' supply chain worldwide and shut down the manufacturing facilities to reduce the virus's risk. The lockdown policies have stopped production and exporting of metal form, which directly hampers its market sizing and growth rate in the global market. However, the reviving policies and growth in demand for the automotive market are expected to fuel the market sizing for metal form in the coming year.

Segmentation Analysis

The flu vaccine market has been classified into whole virus vaccines, split virus vaccines, subunit vaccines, and live attenuated virus vaccines based on the vaccine.

Whole virus vaccines segment accounted for the highest market share in the global market

The whole virus vaccines segment held dominant position with major share in terms of value in the global market and is projected to retain at its position over the forecast period. Whereas the live attenuated virus vaccines segment is projected to record a considerable growth rate in the global market during the forecast period, owing to the increasing adoption of advanced vaccines for prevention purposes.

The flu vaccine market has been classified into anti-intrusion bars, heat exchangers, sound insulation, and others based on the application.

Adults and Children over 3 years segment dominated the global flu vaccine market in 2019

The adults and children, aged 3 years' and above segment is estimated to contribute the maximum share in terms of value in the target market due to increasing incidences of flu viruses among adults and children over 3 years of age at a global level.

Source: DataM Intelligence Analysis (2019)

Geographical Analysis

Based on geography, the study analyzes the flu vaccine market in the global market, including North America, Asia-Pacific, Europe, South America, and the Middle East & Africa.

North America leads the global market throughout the forecast period

The North America market is estimated to hold the dominant position in the global flu vaccines market. This is due to the government's increasing initiatives, such as health programs for expanding awareness concerning influenza, its possible effects, and flu vaccination in countries in the region. Highly developed healthcare infrastructure and the existence of favorable reimbursement policies in countries such as Canada are additional factors projected to boost market growth in countries in the region. The European market is expected to follow North America market, in terms of revenue contribution in the overall market.

The Asia Pacific flu vaccine market is projected to register the highest CAGR in the global market over the forecast period, due to increasing awareness regarding flu vaccination and government initiatives for free flu vaccinations in countries in the region. Moreover, the increasing patient pool for flu in several developing and poorly developed countries is expected to support growth of the market in the region.

Competitive Landscape

The flu vaccine market is highly competitive, owing to the presence of big food brands. The critical flu vaccine players which are contributing to the growth of the global market include AstraZeneca, GlaxoSmithKline PLC, Sanofi, Abbott Laboratories, Seqirus, Mitsubishi Tanabe Pharma, Serum Institute of India Pvt. Ltd, Mylan NV, GDK Biotechnology, Hualan Biological Engineering Inc., Adimmune Corporation, Sinovac Biotech, Changchun Institute of Biological Products, among others. The major players are adopting new launch based on new material launches and expansion strategies for global growth in the flu vaccine market.   

AstraZeneca

Overview: AstraZeneca Plc is a holding company that focusses in the research, development, and manufacturing of pharmaceutical products. Its pipeline are used for the following therapy areas: cardiovascular, oncology, metabolism, renal, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Product Portfolio: The company's portfolio comprises Gastrointestinal, Respiratory, inflammation and autoimmunity, Oncology, Infection, Cardiovascular and metabolism and Neuroscience, among others.

Why Purchase the Report?

Visualize the flu vaccine market segmentation composition by type, application, distribution channel and region, highlighting the critical commercial assets and players.

Identify commercial opportunities in the flu vaccine market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of flu vaccine market - level 3 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global flu vaccine market report would provide access to an approx. 66 market data table, 62 figures, and 210 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Suggestions for Related Market Report:

Global Vaccine Market

Global BCG Vaccine Market

Global Vaccine Vial Market

Global Injection Market

Table of Contents

Table of Contents

Flu Vaccine Market Methodology and Scope

Research Methodology

Research Objective and Scope of the Report

Flu Vaccine Market - Market Definition and Overview

Flu Vaccine Market - Executive Summary

Market Snippet by Type

Market Snippet by Distribution Channel

Market Snippet by Application

Market Snippet by Region

Flu Vaccine Market - Market Dynamics

Market Impacting Factors

Drivers

Sustained investments help to scale up production of tailor-made flu vaccines

Increasing demand for universal flu vaccines

Restraints:

High cost of the product coupled with the dosage of the vaccine to limit adoption

Opportunity

Impact Analysis

Flu Vaccine Market - Industry Analysis

Porter's Five Forces Analysis

Supply Chain Analysis

Value Chain Analysis

PEST Analysis

Pricing Analysis

Regulatory Analysis

Reimbursement Analysis

Unmet Needs

Patent Trends

Flu Vaccine Market - COVID-19 Analysis

Analysis of Covid-19 on the Market

Before COVID-19 Market Scenario

Present COVID-19 Market Scenario

After COVID-19 or Future Scenario

Pricing Dynamics Amid Covid-19

Demand-Supply Spectrum

Government Initiatives Related to the Market During Pandemic

Manufacturers Strategic Initiatives

Conclusion 

Flu Vaccine Market - By Type

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment

Market Attractiveness Index, By Type Segment

Whole virus vaccines*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Split vurus vaccines

Subunit vaccines

Live attenuated virus vaccines

Flu Vaccine Market - By Distribution Channel

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment

Market Attractiveness Index, By Distribution Channel Segment

Institutional*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Hospitals

Community clinics

Public health agencies

Workplaces

Retails

Retail pharmacy

Mail order pharmacy

Flu Vaccine Market - By Application

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment

Market Attractiveness Index, By Application Segment

For Children below 3 years*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

For Adults and Children over 3 years

Flu Vaccine Market - By Region

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

Market Attractiveness Index, By Region

North America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

U.S.

Canada

Mexico

Europe

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Germany

U.K.

France

Italy

Spain

Rest of Europe

South America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Brazil

Argentina

Rest of South America

Asia Pacific

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

China

India

Japan

Australia

Rest of Asia Pacific

Middle East and Africa

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Flu Vaccine Market - Competitive Landscape

Competitive Scenario

Market Positioning/Share Analysis

Mergers and Acquisitions Analysis

Flu Vaccine Market- Company Profiles

AstraZeneca*

Company Overview

Product Portfolio and Description

Key Highlights

Financial Overview

GlaxoSmithKline PLC

Sanofi

Abbott Laboratories

Seqirus

Mitsubishi Tanabe Pharma

Serum Institute of India Pvt. Ltd

Mylan NV

GDK Biotechnology

Hualan Biological Engineering Inc.

Adimmune Corporation

Sinovac Biotech

Changchun Institute of Biological Products (List Not Exhaustive)

Flu Vaccine Market - Premium Insights

Flu Vaccine Market - DataM Intelligence

Appendix

About Us and Services

Contact Us